Understanding Choreoacanthocytosis (ChAc)

Receiving a diagnosis of choreoacanthocytosis (also known as ChAc or VPS13A disease) often marks the end of a long and exhausting “diagnostic odyssey” ^[1]. For many patients and families, this journey involves years of unexplained symptoms, multiple doctor visits, and sometimes conflicting names for the condition ^[1][2]. Finding a definitive answer can bring a powerful mix of relief that the search is over, and grief regarding the nature of the condition ^[3].

Understanding Your Diagnosis

Modern medical guidelines increasingly prefer the name VPS13A disease over the older term “choreoacanthocytosis” ^[2]. While the older name describes the symptoms—chorea (involuntary, dance-like movements) and acanthocytosis (irregular, spiky red blood cells)—the new name identifies the specific genetic cause ^[4][5].

This is an ultra-rare condition, with published sources estimating fewer than about 1,000 cases reported worldwide ^[6]. Because it is so rare, many healthcare providers may never have seen it, which is why your medical team might use an “integrated multidisciplinary approach,” bringing together neurologists, geneticists, and other specialists to manage your care ^[7].

The Biology of VPS13A and Chorein

The root of the condition lies in the VPS13A gene. This gene provides the instructions for making a protein called chorein ^[8]. Chorein acts like a bridge or a ferry within your cells, helping to transfer lipids (fats) between different internal structures called organelles ^[8][9].

When the VPS13A gene is mutated, the body either produces no chorein or produces a version that does not work correctly ^[7]. This disruption in lipid transfer causes several problems at the cellular level:

• Membrane Health: Cells struggle to maintain the health and shape of their outer membranes, which is why some red blood cells develop the spiked, irregular shape (acanthocytes) seen under a microscope ^[10][5].
• Organelle Communication: The lack of chorein disrupts communication between the “powerhouses” of the cell (mitochondria) and the “protein factories” (endoplasmic reticulum) ^[8].
• Neuronal Loss: Over time, these cellular stresses lead to the loss of neurons in specific parts of the brain, particularly the striatum, which is responsible for controlling movement and certain behaviors ^[11][12].

How the Disease is Inherited

VPS13A disease follows an autosomal recessive inheritance pattern ^[13][14]. This means a person must inherit two altered copies of the VPS13A gene—one from each parent—to develop the condition ^[13].

• Carriers: Parents are typically “carriers,” meaning they have one altered gene and one healthy gene. Carriers usually do not show any symptoms of the disease ^[14].
• Risks for Siblings: If both parents are carriers, each of their children has a 25% (1 in 4) chance at conception of being affected by the disease and a 50% chance of being a carrier themselves ^[4].
• Genetic Counseling: Because of these risks, genetic counseling is a standard part of care to help family members understand their own risks and reproductive options ^[4][15].

The Emotional and Psychological Journey

Living with an ultra-rare neurodegenerative disease presents unique psychological challenges. Beyond the physical symptoms, the condition can impact mood, personality, and thinking ^[16].

The literature notes that psychiatric symptoms—such as depression, anxiety, or changes in behavior—can sometimes appear before the movement disorders become obvious ^[16][17]. It is important to monitor emotional well-being closely, as one retrospective review found that roughly 10% of patients experienced significant thoughts of self-harm, making mental health support a critical part of your care plan ^[18].

Safety Instruction: If someone may act on suicidal thoughts, has a plan, or cannot stay safe, contact local emergency services or a mental health crisis line immediately. Do not leave the person alone, and involve a trusted support person.

The rarity of the condition can also lead to a sense of social isolation ^[19]. Connecting with patient organizations and international communities can be an important way to find peer support and stay informed about the latest research and clinical meetings ^[3][20].

Key Terms

• Biallelic: Having two variants in a gene, one on each chromosome.
• In trans: Confirming that the two variants are on opposite chromosomes (one from each parent).
• Pathogenic Variant: A mutation proven to cause disease, unlike a “Variant of Uncertain Significance” (VUS).
• PEG: Percutaneous Endoscopic Gastrostomy, a feeding tube placed directly into the stomach.